These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 4950380

  • 1. Physiologic considerations in the management of hemophilia.
    Briggs DK.
    Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
    [No Abstract] [Full Text] [Related]

  • 2. [On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)].
    Fonio A.
    Schweiz Med Wochenschr; 1966 Dec 24; 96(51):1723-6. PubMed ID: 5973382
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of hemophilia].
    Straub PW.
    Dtsch Med Wochenschr; 1969 Sep 12; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract] [Full Text] [Related]

  • 4. Substitution treatment of hemophilia a and b.
    Duckert F.
    Schweiz Med Wochenschr; 1975 Jun 14; 105(24):783-4. PubMed ID: 1145162
    [Abstract] [Full Text] [Related]

  • 5. [Transfusion therapy of hemophilia A and B].
    Egli H.
    Bibl Haematol; 1967 Jun 14; 27():204-10. PubMed ID: 5595089
    [No Abstract] [Full Text] [Related]

  • 6. Hemophilia in childhood.
    McNeill GF, Schwartz E.
    Pa Med; 1975 Jan 14; 78(1):51-3. PubMed ID: 1128902
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW, Greene WB, Blatt PM, White GC, Roberts HR.
    Instr Course Lect; 1983 Jan 14; 32():210-6. PubMed ID: 6443730
    [Abstract] [Full Text] [Related]

  • 9. [Principles of modern therapy for hemophilia A and B in childhood].
    Ströder J, Ambs E.
    Dtsch Med Wochenschr; 1968 Mar 22; 93(12):539-41. PubMed ID: 5639667
    [No Abstract] [Full Text] [Related]

  • 10. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar 22; 120(3):226-32. PubMed ID: 4544608
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Mar 22; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 13. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K.
    Wien Med Wochenschr; 1977 Jun 10; 127(11):329-37. PubMed ID: 878496
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Circulating anticoagulants during hemophilia].
    Josso F, Cosson A, Gazengel C, Allain JP.
    Rev Fr Transfus; 1972 Dec 10; 15(4):281-98. PubMed ID: 4659598
    [No Abstract] [Full Text] [Related]

  • 16. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H.
    Z Arztl Fortbild (Jena); 1972 Jul 01; 66(13):692-8. PubMed ID: 4636972
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U.
    Thromb Haemost; 1999 Aug 01; 82(2):531-9. PubMed ID: 10605747
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overview of inhibitors.
    Astermark J.
    Semin Hematol; 2006 Apr 01; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.